Ghana vs Maldives: Death rate from cancer
Ghana
53.86 deaths per 100,000 people
in 2021
Maldives
54.56 deaths per 100,000 people
in 2021
Ghana rank
139th
Maldives rank
138th
Death rate from cancer over time
- Ghana
- Maldives
How they compare
Maldives currently reports 54.56 deaths per 100,000 people against 53.86 deaths per 100,000 people in Ghana, a difference of 0.7 deaths per 100,000 people.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Maldives ahead.
Ghana ranks 139th and Maldives ranks 138th of 194 countries.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 61.87 deaths per 100,000 people | 75.17 deaths per 100,000 people | 13.3 deaths per 100,000 people | Maldives |
| 2010s | 58.97 deaths per 100,000 people | 62.21 deaths per 100,000 people | 3.24 deaths per 100,000 people | Maldives |
| 2020s | 55.36 deaths per 100,000 people | 56.69 deaths per 100,000 people | 1.33 deaths per 100,000 people | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from cancer, Ghana or Maldives?
- Maldives, at 54.56 deaths per 100,000 people against 53.86 deaths per 100,000 people in Ghana as of 2021.
- What is the difference in death rate from cancer between Ghana and Maldives?
- 0.7 deaths per 100,000 people, with Maldives ahead.
- How many years of comparable data are there for Ghana and Maldives?
- 22 years are reported by both, from 2000 to 2021.
- How do Ghana and Maldives rank globally for death rate from cancer?
- Ghana ranks 139th and Maldives ranks 138th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes, per 100,000 people.